Release
📈 Stocks
Biohaven Shares Eye Gains as BHV-1530 Data Selected for ENA 2026 Presentation
(18 hours ago)
Biohaven's BHV-1530 Phase 1 study data will be presented at the ENA 2026 symposium, marking a significant clinical milestone for the company's…